These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32957939)
21. N-terminal propeptide of type III collagen in tracheal fluid and serum in preterm infants at risk for bronchopulmonary dysplasia. Heikinheimo M; Halila R; Marttinen E; Raivio K Pediatr Res; 1992 Apr; 31(4 Pt 1):340-3. PubMed ID: 1570200 [TBL] [Abstract][Full Text] [Related]
22. Vitamin D and bronchopulmonary dysplasia in preterm infants. Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562 [TBL] [Abstract][Full Text] [Related]
23. Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia. Hendricks-Muñoz KD; Xu J; Voynow JA Pediatr Pulmonol; 2018 Aug; 53(8):1046-1052. PubMed ID: 29687638 [TBL] [Abstract][Full Text] [Related]
24. Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary Dysplasia. Popova AP; Cui TX; Kaciroti N; Goldsmith AM; Linn MJ; Pryhuber GS; Hershenson MB PLoS One; 2015; 10(12):e0144122. PubMed ID: 26656750 [TBL] [Abstract][Full Text] [Related]
25. Trends in Bronchopulmonary Dysplasia Among Extremely Preterm Infants in Japan, 2003-2016. Nakashima T; Inoue H; Sakemi Y; Ochiai M; Yamashita H; Ohga S; J Pediatr; 2021 Mar; 230():119-125.e7. PubMed ID: 33246013 [TBL] [Abstract][Full Text] [Related]
26. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial. Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130 [TBL] [Abstract][Full Text] [Related]
27. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. Köksal N; Kayik B; Çetinkaya M; Özkan H; Budak F; Kiliç Ş; Canitez Y; Oral B Eur Cytokine Netw; 2012 Jun; 23(2):29-35. PubMed ID: 22591771 [TBL] [Abstract][Full Text] [Related]
28. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia. Kojima T; Sasai M; Kobayashi Y Lancet; 1993 Oct; 342(8878):1023-4. PubMed ID: 8105265 [TBL] [Abstract][Full Text] [Related]
29. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Ramsay PL; DeMayo FJ; Hegemier SE; Wearden ME; Smith CV; Welty SE Am J Respir Crit Care Med; 2001 Jul; 164(1):155-61. PubMed ID: 11435254 [TBL] [Abstract][Full Text] [Related]
30. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia. Kim BI; Lee HE; Choi CW; Jo HS; Choi EH; Koh YY; Choi JH J Perinat Med; 2004; 32(3):282-7. PubMed ID: 15188806 [TBL] [Abstract][Full Text] [Related]
31. Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. Voynow JA; Fisher K; Sunday ME; Cotten CM; Hamvas A; Hendricks-Muñoz KD; Poindexter BB; Pryhuber GS; Ren CL; Ryan RM; Sharp JK; Young SP; Zhang H; Greenberg RG; Herring AH; Davis SD Pediatr Pulmonol; 2020 Apr; 55(4):899-908. PubMed ID: 31995668 [TBL] [Abstract][Full Text] [Related]
32. Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions. Ahmed S; Odumade OA; van Zalm P; Fatou B; Hansen R; Martin CR; Angelidou A; Steen H J Pediatr; 2024 Jul; 270():113774. PubMed ID: 37839510 [TBL] [Abstract][Full Text] [Related]
33. Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants. Wagner BD; Sontag MK; Harris JK; Miller JI; Morrow L; Robertson CE; Stephens M; Poindexter BB; Abman SH; Mourani PM PLoS One; 2017; 12(1):e0170120. PubMed ID: 28129336 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants. Mariduena J; Ramagopal M; Hiatt M; Chandra S; Laumbach R; Hegyi T J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1517-1522. PubMed ID: 32366142 [TBL] [Abstract][Full Text] [Related]
35. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA; JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344 [TBL] [Abstract][Full Text] [Related]
36. Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia in Extreme Preterm Neonates: A Prospective Diagnostic Cohort Study. Mohamed A; Mohsen N; Diambomba Y; Lashin A; Louis D; Elsayed Y; Shah PS J Pediatr; 2021 Nov; 238():187-192.e2. PubMed ID: 34237347 [TBL] [Abstract][Full Text] [Related]
37. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
38. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
39. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants. Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654 [TBL] [Abstract][Full Text] [Related]
40. Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants. Gentle SJ; Travers CP; Nakhmani A; Indic P; Carlo WA; Ambalavanan N Am J Respir Crit Care Med; 2023 Apr; 207(7):899-907. PubMed ID: 36449386 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]